Drug General Information
Drug ID	D0GX8F
Former ID	DNC005127
Drug Name	BN-82002
Indication	Cancer [ICD9: 140-229; ICD10:C00-C96]		Investigative	[527263]
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	M-phase inducer phosphatase 3	Target Info	Inhibitor	[527263]
KEGG Pathway	Cell cycle
	Oocyte meiosis
	Progesterone-mediated oocyte maturation
	MicroRNAs in cancer
PANTHER Pathway	p53 pathway
Pathway Interaction Database	ATR signaling pathway
	ATM pathway
	PLK1 signaling events
	PLK3 signaling events
Reactome	Polo-like kinase mediated events
	Cyclin B2 mediated events
	Activation of ATR in response to replication stress
	RHO GTPases activate PKNs
	Cyclin A/B1 associated events during G2/M transition
	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
WikiPathways	Monoamine Transport
	DNA Damage Response
	ATM Signaling Pathway
	Integrated Pancreatic Cancer Pathway
	Mitotic G2-G2/M phases
	Cell Cycle
	Cell Cycle Checkpoints
	miRNA Regulation of DNA Damage Response
References
Ref 527263	Bioorg Med Chem Lett. 2004 Dec 6;14(23):5809-12.Synthesis of small molecule CDC25 phosphatases inhibitors.
Ref 527263	Bioorg Med Chem Lett. 2004 Dec 6;14(23):5809-12.Synthesis of small molecule CDC25 phosphatases inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.